biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > End is Nearing Fast

<< Previous

Bullboard Posts

Next >>

Comment by LOOPA441on May 18, 2022 8:26pm

157 Views

Post# 34694177

RE:RE:End is Nearing Fast

1)What's your take on the "Accretive M&A" and "liquidity event" comments?

2)Are you expecting anything to be announced before next financials? This timeline seems to have become relevant for some reason.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments